Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 4;146(35):24708-24715.
doi: 10.1021/jacs.4c09490. Epub 2024 Aug 20.

Rh(I)-Catalyzed Regio- and Enantioselective Ring Opening of Vinyl Cyclopropanes

Affiliations

Rh(I)-Catalyzed Regio- and Enantioselective Ring Opening of Vinyl Cyclopropanes

Stephen J Webster et al. J Am Chem Soc. .

Abstract

We describe a Rh(I) catalyzed asymmetric ring opening of racemic vinyl cyclopropanes using aryl boronic acids as C-nucleophiles. When ferrocene-based chiral bisphosphines are used as ligands, the products are obtained with regioselectivities typically 99:1 r.r. and ee's generally between 88 and 96%. A wide range of aryl boronic acids can be used, and the products can be converted into a variety of targets. Preliminary mechanistic studies indicate that Zn(OTf)2 plays a significant role in the reaction by promoting rhodium-ligand complex formation and accelerating the reaction. We expect this method and these mechanistic insights to be useful in the development of new asymmetric methods.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Scheme 1
Scheme 1. Asymmetric Ring Opening of D–A Cyclopropanes
Scheme 2
Scheme 2. Asymmetric Ring Opening of (±)-1,
Experiments performed on 0.5 mmol scale. Enantiomeric ratios were determined by SFC on a chiral nonracemic stationary phase. Enantiomeric ratios unable to be determined. Branched: linear regioselectivity determined by 1H NMR spectroscopic analysis of the crude reaction mixture. +Product was slightly (∼7%) impure. Absolute configurations were assigned by analogy to (S)-11 as determined by X-ray crystallography, which was derivatized from 3a.
Scheme 3
Scheme 3. Product Derivatization
Alkene, Grubbs II, DCM, 45 °C; BnCl, NaH, THF, r.t.; H2, [RhCl(PPh3)3], DCM, r.t.; NaOH, THF, r.t. then CDI, NaOH, THF; TFA, TFAA, 0 °C; m-CPBA, DCM, r.t.; HBPin, [RhCl(PPh3)3], THF, r.t.
Scheme 4
Scheme 4. Diverse Reactivity with D–A Cyclopropanes,,
Experiments performed on 0.5 mmol scale. Enantiomeric ratios were determined by SFC using a chiral nonracemic stationary phase. E/Z and d.r. ratios determined by 1H NMR spectroscopic analysis of the crude reaction mixture. +ee of one diastereomer
Scheme 5
Scheme 5. Kinetics of Ring-opening in Time
Scheme 6
Scheme 6. Effect of Zn(OTf)2 on Catalyst Mixture
Catalyst components are soluble under the conditions used.
Scheme 7
Scheme 7. Zn(OTf)2 Promoted Coordination
Catalyst components are soluble under the conditions used.
Scheme 8
Scheme 8. Rate Dependence on Zn(OTf)2
Scheme 9
Scheme 9. Proposed Mechanism

Similar articles

Cited by

References

    1. Pirenne V.; Muriel B.; Waser J. Catalytic Enantioselective Ring-Opening Reactions of Cyclopropanes. Chem. Rev. 2021, 121, 227–263. 10.1021/acs.chemrev.0c00109. - DOI - PubMed
    1. de Meijere A. Bonding Properties of Cyclopropane and Their Chemical Consequences. Angew. Chem., Int. Ed. 1979, 18, 809–826. 10.1002/anie.197908093. - DOI
    1. Kreft A.; Lücht A.; Grunenberg J.; Jones P. G.; Werz D. B. Kinetic Studies of Donor–Acceptor Cyclopropanes: The Influence of Structural and Electronic Properties on the Reactivity. Angew. Chem., Int. Ed. 2019, 58, 1955–1959. 10.1002/anie.201812880. - DOI - PubMed
    1. Xia Y.; Liu X.; Feng X. Asymmetric Catalytic Reactions of Donor–Acceptor Cyclopropanes. Angew. Chem., Int. Ed. 2021, 60, 9192–9204. 10.1002/anie.202006736. - DOI - PubMed
    1. Ivanova O. A.; Trushkov I. V. Donor-Acceptor Cyclopropanes in the Synthesis of Carbocycles. Chem. Rec. 2019, 19, 2189–2208. 10.1002/tcr.201800166. - DOI - PubMed

LinkOut - more resources